cell

Department of Health – Abu Dhabi, through Abu Dhabi Stem Cells Center, introduces advanced gene-editing therapy for sickle cell disease and thalassemia for first time in UAE دائرة الصحة – أبوظبي توفِّر علاجاً بتقنية التحرير الجيني يقدمه مركز أبوظبي للخلايا الجذعية لمرضى فقر الدم المنجلي والثلاسيميا للمرة الأولى في دولة الإمارات

دائرة الصحة – أبوظبي توفِّر علاجاً بتقنية التحرير الجيني يقدمه مركز أبوظبي للخلايا الجذعية لمرضى فقر الدم المنجلي والثلاسيميا للمرة الأولى في دولة الإمارات

Department of Health – Abu Dhabi, through Abu Dhabi Stem Cells Center, introduces advanced gene-editing therapy for sickle cell disease and thalassemia for first time in UAE

DGN Gate 29 March، 2025

Abu Dhabi, 28 March 2025: The Department of Health – Abu Dhabi (DoH) has announced the introduction...

Tevogen Bio to Study Therapeutic Potential of its Investigational COVID-19 T Cell Therapy in Long COVID

Tevogen Bio to Study Therapeutic Potential of its Investigational COVID-19 T Cell Therapy in Long COVID

Tevogen Bio to Study Therapeutic Potential of its Investigational COVID-19 T Cell Therapy in Long COVID

Karren Franco 24 November، 2022

WARREN, N.J.: Tevogen Bio, a late-stage clinical biotechnology company specializing in the development of cellular immunotherapies in...

Emirates Society of Haematology organizes national Sickle Cell awareness campaign “شعبة الإمارات لأمراض الدم” تنظم حملة وطنية للتوعية بالخلايا المنجلية

“شعبة الإمارات لأمراض الدم” تنظم حملة وطنية للتوعية بالخلايا المنجلية

Emirates Society of Haematology organizes national Sickle Cell awareness campaign

DGNgate 30 June، 2022

to increase public knowledge about the debilitating disease Knowledge of the lifelong condition is very low despite...